Observational analysis finds that tertiary lymphoid structures support therapeutic response in tumors, suggesting new immunotherapy targets.
Key Points
Tertiary lymphoid structures are associated with improved therapeutic responses in cancer patients, enhancing prognosis and survival.
Research indicates that higher density of tertiary lymphoid structures correlates with better outcomes, highlighting their importance in tumor development.
Recent investigations into tertiary lymphoid structures reveal potential strategies for their induction, suggesting pathways to novel therapies.
Advanced techniques combining spatial multi-omics with big data analysis may further elucidate the roles of tertiary lymphoid structures in cancer.